LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities
LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities
London, 4 June 2025– LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces it has entered into a license agreement with Bayer HealthCare LLC, granting LIfT access to Bayer's state-of-the-art Co.Lab facilities in Cambridge, Massachusetts – one of the world's leading hubs for biotech innovation.
This agreement provides LIfT with advanced infrastructure and shared services in a highly collaborative research environment, accelerating the development of its Immuno-Modulatory Alpha Neutrophil (IMAN) platform designed to overcome treatment resistance in solid tumours.
'We see a strong strategic fit with The Bayer Group who have supported using cell therapies to replace dysfunctional cell types in the body in other therapeutic settings, and have developed the world-class facilities and expertise to cost-effectivenely deliver those therapies that we can now look to benefit from. The Bayer Co.Lab offers a unique environment designed to support our kind of biotech innovation, and strengthen our transatlantic presence as we expand as a clinical stage company,' said Alex Blyth, Chief Executive Officer of LIfT Biosciences.
Fiona Mack, Head Co.Lab Cambridge at Bayer HealthCare LLC said: 'The Co.Lab was created to provide cutting-edge biotech companies with the space, resources and network they need to accelerate their research and development. Co.Lab portfolio companies have been selected by a panel of experts within Bayer based upon the scientific merit and potential to substantially impact healthcare. LIfT, with its novel immunotherapy approach, exemplifies the type of company and innovative science that we aim to support and we believe they will be a great fit in our collaborative environment.'
As part of the agreement, LIfT will gain access to a cutting-edge innovation space designed to support the unique needs of early-stage biotechs, with the flexibility to expand into larger 'pods' or private lab areas as operations grow. LIfT will also benefit from centralised procurement and operational support, enabling the team to focus on advancing its IMAN platform efficiently and safely.
About LIfT BioSciencesLIfT Biosciences is a UK & Ireland biotech that is bringing to market a first-in-class allogeneic alpha neutrophil immunotherapy that overcomes treatment resistance in solid tumours by reconstituting immune competence. LIfT's Immunomodulatory Alpha Neutrophils (IMANs) kill in a non-antigen specific manner and turn the tumour microenvironment against the tumour to give a durable total immune response and lasting immunity. The patented breakthrough N-LIfT platform is produced using exceptional stem cells (iPSC or HSC), a proprietary enhancement media and genetic engineering.
The company is preparing initiatives with a range of pharmaceutical license partners to develop a portfolio of engineered IMAN immunotherapies to destroy a range of solid tumours. See www.LIfTBiosciences.com
Further informationInvestors:Alex Blyth ablyth@LIfTBioSciences.com
Media:ICR Healthcare Lindsey Neville, Namrata Taak, Evi Useh liftbiosciences@icrhealthcare.com擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
New coating forms strong, lasting rust barrier for iron with 99.6% efficiency
A new dual-layer coating has been developed that offers 99.6% protection against iron corrosion. Iron gives modern infrastructure strength, from soaring skyscrapers to vital bridges. However, a persistent, unseen foe is always at play, eroding its strength: rust. Iron corrodes when exposed to air and moisture, causing structural damage, safety risks, and extremely high maintenance costs. Current protective solutions are often inadequate, providing only temporary defense against this persistent problem. The researchers from Hebrew University of Jerusalem focused on developing a strong, durable shield for iron that would protect it for decades. "This discovery offers a major leap forward in protecting iron from corrosion," said Professor Elad Gross, who led the development. "By using a specially designed primer, we created a coating that is not only highly effective but also long-lasting. This could reduce maintenance costs, extend the lifespan of iron-based materials, and provide industries with a much more reliable solution," Gross added. Metals naturally corrode over time, but the rate for each differs. Iron is known to rust quickly, but gold and silver can resist deterioration for decades or centuries. A study conducted some time ago indicated that the global expense of corrosion amounted to a whopping US$2.5 trillion. Though protective coatings are available, many frequently break down, failing to provide lasting protection. This development features a dual-layer coating: a thin molecular primer paired with a tough polymer layer. Overall, it creates a durable, long-lasting barrier against rust. The coating development follows a two-pronged approach. First, an ultra-thin molecular primer made of N-Heterocyclic Carbene (NHC) forms an incredibly tight, chemical bond directly with the iron surface. Acting as the ultimate bond, this primer ensures the tough polymer layer adheres strongly, creating an unbreakable protective barrier. The coating remains intact, even in the harshest conditions, like excessive and prolonged exposure to highly corrosive saltwater. Under rigorous testing, the dual-layer coating proved remarkably effective at reducing corrosion. Moreover, thanks to this strong connection, the coating is tougher than standard options that tend to wear down or flake off. The coating, if widely adopted, promises to increase the durability of iron-based products in construction, transportation, and manufacturing. It could reduce maintenance costs for bridges, pipelines, and ships. 'By reducing the need for frequent repairs and replacements, this coating could also contribute to more sustainable and cost-effective material use,' the researchers noted. A recent report indicates that the 'corrosion inhibitor market' is valued at $8.93 billion and is predicted to grow by 3.6% annually between 2025 and 2030. Earlier, researchers from the Indian Institute of Technology (IIT) - Bombay developed a novel technique to measure the degradation rate of protective coatings on iron. Reportedly, the team used the combination of hydrogen permeation-based potentiometry (HPP) and electrochemical impedance spectroscopy (EIS). This technique could lead to precise measurement of degradation right where the organic coating meets the metal. The new findings were published in the journal Angewandte Chemie International Edition.
Business Wire
a day ago
- Business Wire
N‑able Honored with Two Stevies at the 2025 American Business Awards®
BURLINGTON, Mass.--(BUSINESS WIRE)-- N-able, Inc. (NYSE: NABL), a global software company delivering a unified cyber resiliency platform to manage, secure, and recover, announced it was presented with Stevie® awards across two different categories at the 23rd annual American Business Awards® held in New York City on June 10. The People Team at N-able earned the gold award for Human Resources Team of the Year, recognized for their values-driven approach to foster an extraordinary workplace culture. The team places people at the center of everything they do, and their dedication to Empowering N-ablite Excellence is evidenced through the various global programs and initiatives they have spearheaded to drive organizational success. N-able earned the silver award for Cloud Storage & Backup Solution for its breakthrough cloud architecture product, Cove Data Protection. The introduction of Standby Image for Microsoft Azure and VMware ESXi expanded disaster recovery flexibility. This virtualized data protection solution automatically creates bootable VM images, offering IT service providers a more cost-effective, simplified Disaster Recovery as a Service (DRaaS), aligned with the N-able Ecoverse vision of seamless ecosystem integration. 'I'm incredibly proud of our People Team and the N-ablites behind Cove Data Protection for earning these two prestigious Stevie awards,' said John Pagliuca, CEO, N-able. 'These recognitions are a testament to the passion and purpose that drive our company forward—from fostering a culture to enable employee excellence, driving engagement across 15 countries, to delivering best-of-breed cybersecurity solutions that ensure our partners' business resilience. These achievements reflect the hard work and dedication of all N-ablites, and I'm excited for what's ahead.' The Stevie American Business Awards are the premier business awards program in the U.S. More than 3,600 nominations from organizations of all sizes and in virtually every industry were submitted this year for consideration in a wide range of categories. More than 250 professionals worldwide participated in the judging process to select this year's Stevie Award winners. Details about The American Business Awards and the list of 2025 Stevie winners are available at About N-able At N-able, our mission is to protect businesses against evolving cyberthreats with a unified cyber resiliency platform to manage, secure, and recover. Our scalable technology infrastructure includes AI-powered capabilities, market-leading third-party integrations, and the flexibility to employ technologies of choice—to transform workflows and deliver critical security outcomes. Our partner-first approach combines our products with experts, training, and peer-led events that empower our customers to be secure, resilient, and successful. © 2025 N-able Solutions ULC and N-able Technologies Ltd. All rights reserved. The N-able trademarks, service marks, and logos are the exclusive property of N-able Solutions ULC and N-able Technologies Ltd. All other trademarks are the property of their respective owners. Category: Award About the Stevie Awards Stevie Awards are conferred in nine programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, the Stevie Awards for Sales & Customer Service, and the Stevie Awards for Technology Excellence. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at
Business Wire
2 days ago
- Business Wire
OFS Credit Company Provides May 2025 Net Asset Value Update
CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (Nasdaq: OCCI) ('OFS Credit', the 'Company', 'we', 'us' or 'our'), an investment company that primarily invests in collateralized loan obligation ('CLO') equity and debt securities, today announced the following net asset value ('NAV') estimate at May 31, 2025. Management's unaudited estimate of the range of our NAV per share of our common stock at May 31, 2025 is between $6.23 and $6.33. This estimate is not a comprehensive statement of our financial condition or results for the month ended May 31, 2025. This estimate did not undergo the Company's typical quarter-end financial closing procedures. We advise you that the current estimates of our NAV per share may differ materially from future NAV estimates or determinations, including the determination for the period ending July 31, 2025, which will be reported in our monthly report on Form N-PORT. Our financial condition, including the fair value of our portfolio investments, and results of operations may be materially impacted after May 31, 2025 by circumstances and events that are not yet known. To the extent our portfolio investments are adversely impacted by interest rate and inflation rate changes, the ongoing war between Russia and Ukraine, the agenda of the new U.S. Presidential administration, including the impact of tariff enactment and tax reductions, trade disputes with other countries, instability in the U.S. and international banking systems, the risk of recession or a shutdown of U.S. government services and related market volatility, or by other factors, we may experience a material adverse impact on our future NAV, net investment income, the underlying value of our investments, our financial condition and the financial condition of our portfolio investments. The preliminary financial data included in this press release has been prepared by, and is the responsibility of, OFS Credit's management. KPMG LLP has not audited, reviewed, compiled, or applied agreed-upon procedures with respect to the preliminary financial data. Accordingly, KPMG LLP does not express an opinion or any other form of assurance with respect thereto. About OFS Credit Company, Inc. OFS Credit is a non-diversified, externally managed closed-end management investment company. The Company's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation, which we seek to achieve primarily through investments in CLO equity and debt securities. The Company's investment activities are managed by OFS Capital Management, LLC, an investment adviser registered under the Investment Advisers Act of 1940 1, as amended, and headquartered in Chicago, Illinois with additional offices in New York and Los Angeles. Forward-Looking Statements Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects may constitute forward-looking statements. Forward-looking statements can be identified by terminology such as 'anticipate', 'believe', 'could', 'could increase the likelihood', 'estimate', 'expect', 'intend', 'is planned', 'may', 'should', 'will', 'will enable', 'would be expected', 'look forward', 'may provide', 'would' or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including those risks, uncertainties and factors referred to in documents that may be filed by OFS Credit from time to time with the Securities and Exchange Commission, as well as interest rate and inflation rate changes, the ongoing war between Russia and Ukraine, the agenda of the new U.S. Presidential administration, including the impact of tariff enactment and tax reductions, trade disputes with other countries, instability in the U.S. and international banking systems, the risk of recession or a shutdown of U.S government services and related market volatility on our business, our portfolio companies, our industry and the global economy. As a result of such risks, uncertainties and factors, actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. OFS Credit is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise. 1 Registration does not imply a certain level of skill or training OFS® and OFS Credit® are registered trademarks of Orchard First Source Asset Management, LLC. OFS Capital Management™ is a trademark of Orchard First Source Asset Management, LLC.
